CG Oncology’s (CGON) Overweight Rating Reiterated at Morgan Stanley
CG Oncology (NASDAQ:CGON – Get Free Report)‘s stock had its “overweight” rating reissued by equities research analysts at Morgan Stanley in a research report issued on Friday,Benzinga reports. They currently have a $55.00 target price on the stock. Morgan Stanley’s price target would suggest a potential upside of 105.84% from the company’s current price. Several […]
CG Oncology (NASDAQ:CGON – Get Free Report)‘s stock had its “overweight” rating reissued by equities research analysts at Morgan Stanley in a research report issued on Friday,Benzinga reports. They currently have a $55.00 target price on the stock. Morgan Stanley’s price target would suggest a potential upside of 105.84% from the company’s current price. Several […]
